"New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.
paper
Cited
Public
Unavailable
- Authors
- Chakravarthy, Manu V; Pan, Zhijun; Zhu, Yimin; Tordjman, Karen; Schneider, Jochen G; Coleman, Trey; Turk, John; Semenkovich, Clay F
- Year
- 2005
- Journal
- Cell metabolism
- PMID
- 16054078
- DOI
- 10.1016/j.cmet.2005.04.002
De novo lipogenesis is an energy-expensive process whose role in adult mammals is poorly understood. We generated mice with liver-specific inactivation of fatty-acid synthase (FAS), a key lipogenic enzyme. On a zero-fat diet, FASKOL (FAS knockout in liver) mice developed hypoglycemia and fatty liver, which were reversed with dietary fat. These phenotypes were also observed after prolonged fasting, similarly to fasted PPARalpha-deficiency mice. Hypoglycemia, fatty liver, and defects in expression of PPARalpha target genes in FASKOL mice were corrected with a PPARalpha agonist. On either zero-fat or chow diet, FASKOL mice had low serum and hepatic cholesterol levels with elevated SREBP-2, decreased HMG-CoA reductase expression, and decreased cholesterol biosynthesis; these were also corrected with a PPARalpha agonist. These results suggest that products of the FAS reaction regulate glucose, lipid, and cholesterol metabolism by serving as endogenous activators of distinct physiological pools of PPARalpha in adult liver.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | 2019 | 29568101 |
| Role of PPARΞ± in Hepatic Carbohydrate Metabolism. | 2010 | 20936117 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Endocrine regulation of the hepatic fasting response: cues, cooperation and consequences. | Goldberg D et al. | β | 2026 | β |
| Genetic deletion of miR-200a/200b increases growth and feed conversion efficiency in yellow catfish. | Wang X et al. | β | 2026 | β |
| Tissue-specific epigenetic regulation of fat metabolism in pigs through integrated analysis of DNA methylation and gene expression networks. | Kim DY et al. | β | 2026 | β |
| Adipose tissue-derived PRXL2A suppresses hepatic lipogenesis in a study with male mice. | Li Z et al. | β | 2025 | β |
| A hierarchical hepatic de novo lipogenesis substrate supply network utilizing pyruvate, acetate, and ketones. | Rauckhorst AJ et al. | β | 2025 | β |
| Bempedoic acid suppresses diet-induced hepatic steatosis independently of ATP-citrate lyase. | Liu JY et al. | β | 2025 | β |
| Deletion of Tfap2a in hepatocytes and macrophages promotes the progression of hepatocellular carcinoma by regulating SREBP1/FASN/ACC pathway and anti-inflammatory effect of IL10. | Li Z et al. | β | 2025 | β |
| Effect of ammonium fluoride as a mobile phase additive on quantitativity of fatty acids in electrospray ionization-liquid chromatography-tandem mass spectrometry. | Kawabata K et al. | β | 2025 | β |
| Enhancing newborn screening sensitivity and specificity for missed NICCD using selected amino acids and acylcarnitines. | Wang P et al. | β | 2025 | β |
| Fatty acid synthase global inducible knockout does not alter brain fatty acid concentrations but attenuates cholesterol synthesis in the adult mouse. | Seeger DR et al. | β | 2025 | β |
| Fatty Acid Synthase regulates glucose and energy homeostasis via POMC neurons and adrenergic signals. | Leon-Mercado L et al. | β | 2025 | β |
| Growth hormone excess drives liver aging via increased glycation stress. | Singh P et al. | β | 2025 | β |
| Gut microbiota mediates SREBP-1c-driven hepatic lipogenesis and steatosis in response to zero-fat high-sucrose diet. | Bergentall M et al. | β | 2025 | β |
| Licochalcone A ameliorates lipid accumulation in metabolic dysfunction-associated steatotic liver disease via upregulating PPARΞ±/CPT1Ξ±. | Zhu W et al. | β | 2025 | β |
| Liver Metabolism at the Crossroads: The Reciprocal Control of Nutrient-Sensing Nuclear Receptors and Autophagy. | Kim EY et al. | β | 2025 | β |
| Mammalian fatty acid synthase: a commonly used viral host dependency factor and a putative target for host-targeted broad-spectrum antiviral therapeutic development. | Loperena GonzΓ‘lez PN et al. | β | 2025 | β |
| Repeated fasting events sensitize enhancers, transcription factor activity and gene expression to support augmented ketogenesis. | Korenfeld N et al. | β | 2025 | β |
| Targeting fatty acid synthase reduces aortic atherosclerosis and inflammation. | Meade R et al. | β | 2025 | β |
| Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease. | Zhang Y et al. | β | 2025 | β |
| The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease. | Zhang Y et al. | β | 2025 | β |
| The Emerging Role of Peroxisome Proliferator-Activated Receptors in Cancer Stemness. | Parejo-Alonso B et al. | β | 2025 | β |
| Unraveling Tissue-Specific Fatty Acid Biosynthesis and Inter-Tissue Crosstalk in Mice through Stable-Isotope Tracing Metabolomics. | Xing B et al. | β | 2025 | β |
| Chlorogenic Acid Attenuates Hepatic Steatosis by Suppressing ZFP30. | Ding H et al. | β | 2024 | β |
| Comparative Study on the Effects of Four Plant Protein Sources on the Liver and Intestinal Health of Largemouth Bass, <i>Micropterus salmoides</i>. | Yao S et al. | β | 2024 | β |
| Endoplasmic reticulum stress induces hepatic steatosis through interaction between PPARΞ± and FoxO6 in vivo and in vitro. | Kim DH | β | 2024 | β |
| Exploring the dynamic three-dimensional chromatin architecture and transcriptional landscape in goose liver tissues underlying metabolic adaptations induced by a high-fat diet. | Gao G et al. | β | 2024 | β |
| Exposure to Succinate Leads to Steatosis in Non-Obese Non-Alcoholic Fatty Liver Disease by Inhibiting AMPK/PPARΞ±/FGF21-Dependent Fatty Acid Oxidation. | Yang H et al. | β | 2024 | β |
| Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27<sup>KIP1</sup> Regulation. | Cigliano A et al. | β | 2024 | β |
| Glutathione synthesis in the mouse liver supports lipid abundance through NRF2 repression. | Asantewaa G et al. | β | 2024 | β |
| Impact of prenatal THC exposure on lipid metabolism and microbiota composition in rat offspring. | Murru E et al. | β | 2024 | β |
| Integrated metabolomic and transcriptomic analysis reveals the effects and mechanisms of Jinqi Jiangtang tablets on type 2 diabetes. | Song Z et al. | β | 2024 | β |
| Lipid sensing by PPARΞ±: Role in controlling hepatocyte gene regulatory networks and the metabolic response to fasting. | Fougerat A et al. | β | 2024 | β |
| Mechanisms of hepatic fatty acid oxidation and ketogenesis during fasting. | Ruppert PMM et al. | β | 2024 | β |
| New stilbenes from Cajanus cajan inhibit adipogenesis in 3T3-L1 adipocytes through down-regulation of PPARΞ³. | Yao L et al. | β | 2024 | β |
| Nobiletin Protects Against Alcoholic Liver Disease in Mice via the BMAL1-AKT-Lipogenesis Pathway. | Li X et al. | β | 2024 | β |
| Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis. | Engin A | β | 2024 | β |
| Pathogenesis and Management of Citrin Deficiency. | Hayasaka K | β | 2024 | β |
| Sesaminol alters phospholipid metabolism and alleviates obesity-induced NAFLD. | Rajendran R et al. | β | 2024 | β |
| Therapeutic potential of Ξ²-hydroxybutyrate in the management of pancreatic neoplasms: exploring novel diagnostic and treatment strategies. | Vaezi MA et al. | β | 2024 | β |
| The roles of nuclear receptors in cholesterol metabolism and reverse cholesterol transport in nonalcoholic fatty liver disease. | Li Z et al. | β | 2024 | β |
| Unraveling brain palmitic acid: Origin, levels and metabolic fate. | Smith ME et al. | β | 2024 | β |
| Unraveling the metabolic activities of bioactive compounds on cellular models of hepatosteatosis and adipogenesis through docking analysis with PPARs. | Diab F et al. | β | 2024 | β |
| Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program. | Guilherme A et al. | β | 2023 | β |
| ACSS2 gene variants determine kidney disease risk by controlling de novo lipogenesis in kidney tubules. | Mukhi D et al. | β | 2023 | β |
| De novo lipogenesis fuels adipocyte autophagosome and lysosome membrane dynamics. | Rowland LA et al. | β | 2023 | β |
| Effect of ammonia stress on AMPK regulating-carbohydrate and lipid metabolism in Chinese striped-neck turtle (Mauremys sinensis). | Khan I et al. | β | 2023 | β |
| Effects of hepatic mitochondrial pyruvate carrier deficiency on <i>de novo</i> lipogenesis and gluconeogenesis in mice. | Yiew NKH et al. | β | 2023 | β |
| Futile cycle of Ξ²-oxidation and de novo lipogenesis are associated with essential fatty acids depletion in lipoatrophy. | Chaves-Filho AB et al. | β | 2023 | β |
| Glucose-induced and ChREBP: MLX-mediated lipogenic program promotes hepatocellular carcinoma development. | Yu A et al. | β | 2023 | β |
| Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models. | Matsukawa T et al. | β | 2023 | β |
| Insulin Regulation of Hepatic Lipid Homeostasis. | Uehara K et al. | β | 2023 | β |
| Lipid and glucose metabolism in senescence. | Liu B et al. | β | 2023 | β |
| Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD). | Syed-Abdul MM | β | 2023 | β |
| Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease. | Gao R et al. | β | 2023 | β |
| Nickel Nanoparticles Induced Hepatotoxicity in Mice via Lipid-Metabolism-Dysfunction-Regulated Inflammatory Injury. | Zhou S et al. | β | 2023 | β |
| Physiological and pathological roles of lipogenesis. | Jeon YG et al. | β | 2023 | β |
| Porphyra haitanensis Polysaccharides Attenuates Blood Lipid via Gut-Liver Axis in Diet-Induced High-Fat Mesocricetus auratus through Multiple Integrated Omics. | Zeng H et al. | β | 2023 | β |
| Selenium-dependent glutathione peroxidase 1 regulates transcription of elongase 3 in murine tissues. | Sun Z et al. | β | 2023 | β |
| Sex differences in paternal arsenic-induced intergenerational metabolic effects are mediated by estrogen. | Xue Y et al. | β | 2023 | β |
| The Interrelation Between Hypothyroidism and Non-alcoholic Fatty Liver Disease, a Cross-sectional Study. | Elshinshawy S et al. | β | 2023 | β |
| The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy. | Sun J et al. | β | 2023 | β |
| Altered Peroxisome Proliferator-Activated Receptor Alpha Signaling in Variably Diseased Peripheral Arterial Segments. | Engel C et al. | β | 2022 | β |
| A Short-Term High-Fat Diet Improved the Survival of Fat Grafts in Mice by Promoting Macrophage Infiltration and Angiogenesis. | Niu X et al. | β | 2022 | β |
| ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARΞ± activity. | Fougerat A et al. | β | 2022 | β |
| Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis : Blockage of NDUFB9-SCD1 pathway inhibits adipogenesis. | Zhu S et al. | β | 2022 | β |
| De novo lipogenesis fuels adipocyte autophagosome membrane dynamics | Rowland LA et al. | β | 2022 | β |
| Epigallocatechin-3-gallate ameliorates hepatic damages by relieve FGF21 resistance and promotion of FGF21-AMPK pathway in mice fed a high fat diet. | Zhang Y et al. | β | 2022 | β |
| Exosomes from Short-Term High-Fat or High-Sucrose Fed Mice Induce Hepatic Steatosis through Different Pathways. | CastaΓ±o C et al. | β | 2022 | β |
| Genetic Reduction of Glucose Metabolism Preserves Functional Ξ²-Cell Mass in KATP-Induced Neonatal Diabetes. | Yan Z et al. | β | 2022 | β |
| Lipid-lowering activity of metformin-soluble soybean polysaccharide nanoparticles. | He H et al. | β | 2022 | β |
| Lipogenesis inhibitors: therapeutic opportunities and challenges. | Batchuluun B et al. | β | 2022 | β |
| Liver-specific overexpression of lipoprotein lipase improves glucose metabolism in high-fat diet-fed mice. | Shimizu K et al. | β | 2022 | β |
| PPARΞ±: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases. | Lin Y et al. | β | 2022 | β |
| PTEN Deletion in Adult Mice Induces Hypoinsulinemia With Concomitant Low Glucose Levels. | Crespo-Masip M et al. | β | 2022 | β |
| Reducing ether lipids improves Drosophila overnutrition-associated pathophysiology phenotypes via a switch from lipid storage to beta-oxidation. | Santoro C et al. | β | 2022 | β |
| Regulation of Glucose, Fatty Acid and Amino Acid Metabolism by Ubiquitination and SUMOylation for Cancer Progression. | Zhu S et al. | β | 2022 | β |
| Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1Ξ± Hypoxia Sensor. | Golinska MA et al. | β | 2022 | β |
| Targeted inhibition of PPARΞ± ameliorates CLA-induced hypercholesterolemia via hepatic cholesterol biosynthesis reprogramming. | Liu HY et al. | β | 2022 | β |
| Tissue-Specific Downregulation of Fatty Acid Synthase Suppresses Intestinal Adenoma Formation via Coordinated Reprograming of Transcriptome and Metabolism in the Mouse Model of Apc-Driven Colorectal Cancer. | Drury J et al. | β | 2022 | β |
| Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4. | Wang B et al. | β | 2021 | β |
| Co-option of PPARΞ± in the regulation of lipogenesis and fatty acid oxidation in CLA-induced hepatic steatosis. | Cai D et al. | β | 2021 | β |
| Core circadian clock transcription factor BMAL1 regulates mammary epithelial cell growth, differentiation, and milk component synthesis. | Casey T et al. | β | 2021 | β |
| Dietary Lipids and Dyslipidemia in Chronic Kidney Disease. | Kochan Z et al. | β | 2021 | β |
| Fatty Acid Synthase Inhibitor Platensimycin Intervenes the Development of Nonalcoholic Fatty Liver Disease in a Mouse Model. | Su M et al. | β | 2021 | β |
| Fatty Acid Synthase-Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD. | Hu Y et al. | β | 2021 | β |
| From Food to Genes: Transcriptional Regulation of Metabolism by Lipids and Carbohydrates. | Bravo-Ruiz I et al. | β | 2021 | β |
| From Liver Fat to Cancer: Perils of the Western Diet. | Kim JY et al. | β | 2021 | β |
| Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. | Albhaisi S et al. | β | 2021 | β |
| Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss. | Bastos DC et al. | β | 2021 | β |
| Glucose-mediated de novo lipogenesis in photoreceptors drives early diabetic retinopathy. | Rajagopal R et al. | β | 2021 | β |
| Hepatic <i>MIR20B</i> promotes nonalcoholic fatty liver disease by suppressing <i>PPARA</i>. | Lee YH et al. | β | 2021 | β |
| Hepatic transcriptional responses to fasting and feeding. | Bideyan L et al. | β | 2021 | β |
| Hypoxia via ERK Signaling Inhibits Hepatic PPARΞ± to Promote Fatty Liver. | Mooli RGR et al. | β | 2021 | β |
| Lipid droplet availability affects neural stem/progenitor cell metabolism and proliferation. | Ramosaj M et al. | β | 2021 | β |
| Loss of Acot12 contributes to NAFLD independent of lipolysis of adipose tissue. | Park S et al. | β | 2021 | β |
| Measurement of lipogenic flux by deuterium resolved mass spectrometry. | Fu X et al. | β | 2021 | β |
| Metabolic-associated fatty liver disease and lipoprotein metabolism. | Heeren J et al. | β | 2021 | β |
| Mobilization efficiency is critically regulated by fat via marrow PPARΞ΄. | Suzuki T et al. | β | 2021 | β |
| Peroxisomal Ξ²-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis. | Ding L et al. | β | 2021 | β |
| PPARs in liver physiology. | Berthier A et al. | β | 2021 | β |
| Regulation of maternal-fetal metabolic communication. | Bowman CE et al. | β | 2021 | β |
| Roles of IΞΊB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease. | Huh JY et al. | β | 2021 | β |
| Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men. | Maseroli E et al. | β | 2021 | β |
| The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation. | Yang Z et al. | β | 2021 | β |
| Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH. | Cariello M et al. | β | 2021 | β |
| TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial. | Loomba R et al. | β | 2021 | β |
| Whole Transcriptome Analysis Reveals a Potential Regulatory Mechanism of LncRNA-FNIP2/miR-24-3p/<i>FNIP2</i> Axis in Chicken Adipogenesis. | Guo L et al. | β | 2021 | β |
| Alcohol and Liver Clock Disruption Increase Small Droplet Macrosteatosis, Alter Lipid Metabolism and Clock Gene mRNA Rhythms, and Remodel the Triglyceride Lipidome in Mouse Liver. | Valcin JA et al. | β | 2020 | β |
| Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. | Che L et al. | β | 2020 | β |
| CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARΞ± expression. | Yang Z et al. | β | 2020 | β |
| Cytochrome P450-derived eicosanoids and inflammation in liver diseases. | Shoieb SM et al. | β | 2020 | β |
| Effects of prenatal bisphenol A exposure on the hepatic transcriptome and proteome in rat offspring. | Nguyen HT et al. | β | 2020 | β |
| Fatty Acid Synthase: An Emerging Target in Cancer. | Fhu CW et al. | β | 2020 | β |
| Fatty Acid Synthase Inhibitor TVB-2640 Reduces Hepatic de Novo Lipogenesis in Males With Metabolic Abnormalities. | Syed-Abdul MM et al. | β | 2020 | β |
| Fluoxetine regulates glucose and lipid metabolism via the PI3KβAKT signaling pathway in diabetic rats. | Yang H et al. | β | 2020 | β |
| High Glucose and Liver Fatty Acid Binding Protein Gene Ablation Differentially Impact Whole Body and Liver Phenotype in High-Fat Pair-Fed Mice. | Martin GG et al. | β | 2020 | β |
| Identifying strategies to target the metabolic flexibility of tumours. | MΓ©ndez-Lucas A et al. | β | 2020 | β |
| <i>FASN</i>-Mediated Lipid Metabolism Regulates Goose Granulosa Cells Apoptosis and Steroidogenesis. | Chen X et al. | β | 2020 | β |
| Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. | Tan M et al. | β | 2020 | β |
| Metabolic Effects of Selective Deletion of Group VIA Phospholipase A<sub>2</sub> from Macrophages or Pancreatic Islet Beta-Cells. | Turk J et al. | β | 2020 | β |
| Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease. | Fougerat A et al. | β | 2020 | β |
| Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis. | Jia J et al. | β | 2020 | β |
| Satellite glial cells promote regenerative growth in sensory neurons. | Avraham O et al. | β | 2020 | β |
| Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels. | Johnson EL et al. | β | 2020 | β |
| Successful treatment of adult-onset type II citrullinemia with a low-carbohydrate diet and L-arginine after DNA analysis produced a definitive diagnosis. | Unita S et al. | β | 2020 | β |
| The metabolic basis of nonalcoholic steatohepatitis. | Chakravarthy MV et al. | β | 2020 | β |
| A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors. | Goto T | β | 2019 | β |
| Circulating serum fatty acid synthase is elevated in patients with diabetes and carotid artery stenosis and is LDL-associated. | De Silva GS et al. | β | 2019 | β |
| CNS myelination and remyelination depend on fatty acid synthesis by oligodendrocytes. | Dimas P et al. | β | 2019 | β |
| Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions. | Jonscher KR et al. | β | 2019 | β |
| CYP2A6 is associated with obesity: studies in human samples and a high fat diet mouse model. | Wang K et al. | β | 2019 | β |
| Drugging cancer metabolism: Expectations vs. reality. | Montrose DC et al. | β | 2019 | β |
| Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells. | Bueno MJ et al. | β | 2019 | β |
| Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease. | Simoes ICM et al. | β | 2019 | β |
| Fibroblast growth factor 21 in non-alcoholic fatty liver disease. | Tucker B et al. | β | 2019 | β |
| Growth impairment in individuals with citrin deficiency. | Numakura C et al. | β | 2019 | β |
| Hepatocyte Peroxisome Proliferator-Activated Receptor Ξ± Enhances Liver Regeneration after Partial Hepatectomy in Mice. | Xie G et al. | β | 2019 | β |
| Mangiferin Improved Palmitate-Induced-Insulin Resistance by Promoting Free Fatty Acid Metabolism in HepG2 and C2C12 Cells via PPAR<i>Ξ±</i>: Mangiferin Improved Insulin Resistance. | Zhang Q et al. | β | 2019 | β |
| Nutritional Regulation of Gene Expression: Carbohydrate-, Fat- and Amino Acid-Dependent Modulation of Transcriptional Activity. | Haro D et al. | β | 2019 | β |
| Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma. | Che L et al. | β | 2019 | β |
| Peroxisome proliferator-activated receptor Ξ± attenuates high-cholesterol diet-induced toxicity and pro-thrombotic effects in mice. | Lu Y et al. | β | 2019 | β |
| The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPARΞ±. | Iershov A et al. | β | 2019 | β |
| Adult-onset type II citrullinemia: Current insights and therapy. | Hayasaka K et al. | β | 2018 | β |
| An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans. | Mardinoglu A et al. | β | 2018 | β |
| Basic mechanisms of the regulation of L-carnitine status in monogastrics and efficacy of L-carnitine as a feed additive in pigs and poultry. | Ringseis R et al. | β | 2018 | β |
| Comparative Evaluation of Gemcabene and Peroxisome Proliferator-Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease. | Bisgaier CL et al. | β | 2018 | β |
| De novo fatty acid synthesis by Schwann cells is essential for peripheral nervous system myelination. | Montani L et al. | β | 2018 | β |
| Diet-Induced Circadian Enhancer Remodeling Synchronizes Opposing Hepatic Lipid Metabolic Processes. | Guan D et al. | β | 2018 | β |
| Effect of dietary polyunsaturated fatty acid and antioxidant supplementation on the transcriptional level of genes involved in lipid and energy metabolism in swine. | Vitali M et al. | β | 2018 | β |
| Global Analyses of Selective Insulin Resistance in Hepatocytes Caused by Palmitate Lipotoxicity. | Li Z et al. | β | 2018 | β |
| Hepatic Insulin Clearance in Regulation of Systemic Insulin Concentrations-Role of Carbohydrate and Energy Availability. | Bojsen-MΓΈller KN et al. | β | 2018 | β |
| Hexanoic, Octanoic and Decanoic Acids Promote Basal and Insulin-Induced Phosphorylation of the Akt-mTOR Axis and a Balanced Lipid Metabolism in the HepG2 Hepatoma Cell Line. | Rial SA et al. | β | 2018 | β |
| Identification of IQ motif-containing GTPase-activating protein 1 as a regulator of long-term ketosis. | Erickson HL et al. | β | 2018 | β |
| Insights into the role of hepatocyte PPARΞ± activity in response to fasting. | RΓ©gnier M et al. | β | 2018 | β |
| Insights into the Role of PPARΞ²/Ξ΄ in NAFLD. | Chen J et al. | β | 2018 | β |
| Lipoprotein Lipase Deficiency Impairs Bone Marrow Myelopoiesis and Reduces Circulating Monocyte Levels. | Chang CL et al. | β | 2018 | β |
| Liver-specific Repin1 deficiency impairs transient hepatic steatosis in liver regeneration. | Abshagen K et al. | β | 2018 | β |
| Macrophage microRNA-150 promotes pathological angiogenesis as seen in age-related macular degeneration. | Lin JB et al. | β | 2018 | β |
| Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia. | Hayasaka K et al. | β | 2018 | β |
| Microcystis bloom containing microcystin-LR induces type 2 diabetes mellitus. | Zhang Q et al. | β | 2018 | β |
| Molecular Actions of PPARΞ± in Lipid Metabolism and Inflammation. | Bougarne N et al. | β | 2018 | β |
| Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. | Ipsen DH et al. | β | 2018 | β |
| Retinal de novo lipogenesis coordinates neurotrophic signaling to maintain vision. | Rajagopal R et al. | β | 2018 | β |
| The hepatic BMAL1/AKT/lipogenesis axis protects against alcoholic liver disease in mice via promoting PPARΞ± pathway. | Zhang D et al. | β | 2018 | β |
| The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells. | Antonosante A et al. | β | 2018 | β |
| Triglyceride-Rich Lipoproteins. | Kockx M et al. | β | 2018 | β |
| Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation. | Kim CW et al. | β | 2017 | β |
| A key role of nuclear factor Y in the refeeding response of fatty acid synthase in adipocytes. | Nishi-Tatsumi M et al. | β | 2017 | β |
| Cellular fatty acid synthase is required for late stages of HIV-1 replication. | Kulkarni MM et al. | β | 2017 | β |
| Distinct but complementary contributions of PPAR isotypes to energy homeostasis. | Dubois V et al. | β | 2017 | β |
| Endogenous retinoid X receptor ligands in mouse hematopoietic cells. | Niu H et al. | β | 2017 | β |
| Fatty acid synthase (FASN) as a therapeutic target in breast cancer. | Menendez JA et al. | β | 2017 | β |
| Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target. | Buckley D et al. | β | 2017 | β |
| Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging. | Gong Z et al. | β | 2017 | β |
| Heterologous expression of porcine elongase 6 (<i>ELOVL6</i>) gene in a human cell line. | Gupta S et al. | β | 2017 | β |
| Hyper- and hypo- nutrition studies of the hepatic transcriptome and epigenome suggest that PPARΞ± regulates anaerobic glycolysis. | Soltis AR et al. | β | 2017 | β |
| Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis. | Bellanti F et al. | β | 2017 | β |
| LPS infusion suppresses serum FGF21 levels in healthy adult volunteers. | Lauritzen ES et al. | β | 2017 | β |
| Non-Alcoholic Fatty Liver Disease. | Engin A | β | 2017 | β |
| Nutritional background changes the hypolipidemic effects of fenofibrate in Nile tilapia (Oreochromis niloticus). | Ning LJ et al. | β | 2017 | β |
| Oleate activates SREBP-1 signaling activity in <i>SCD1</i>-deficient hepatocytes. | Lounis MA et al. | β | 2017 | β |
| Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma. | Che L et al. | β | 2017 | β |
| Triglyceride Metabolism in the Liver. | Alves-Bezerra M et al. | β | 2017 | β |
| We Know More Than We Can Tell About Diabetes and Vascular Disease: The 2016 Edwin Bierman Award Lecture. | Semenkovich CF | β | 2017 | β |
| Abnormalities in the Metabolism of Fatty Acids and Triacylglycerols in the Liver of the Goto-Kakizaki Rat: A Model for Non-Obese Type 2 Diabetes. | Karahashi M et al. | β | 2016 | β |
| Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice. | Hu J et al. | β | 2016 | β |
| DAF-16 and TCER-1 Facilitate Adaptation to Germline Loss by Restoring Lipid Homeostasis and Repressing Reproductive Physiology in C. elegans. | Amrit FR et al. | β | 2016 | β |
| Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans. | Li L et al. | β | 2016 | β |
| Fenofibrate Decreases Insulin Clearance and Insulin Secretion to Maintain Insulin Sensitivity. | Ramakrishnan SK et al. | β | 2016 | β |
| Glucocorticoid receptor-PPARΞ± axis in fetal mouse liver prepares neonates for milk lipid catabolism. | Rando G et al. | β | 2016 | β |
| Hepatic Fasting-Induced PPARΞ± Activity Does Not Depend on Essential Fatty Acids. | Polizzi A et al. | β | 2016 | β |
| Hepatic Fatty Acid Oxidation Restrains Systemic Catabolism during Starvation. | Lee J et al. | β | 2016 | β |
| Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans. | Li L et al. | β | 2016 | β |
| Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis. | Sergin I et al. | β | 2016 | β |
| iPLA2Ξ² deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling. | Deng X et al. | β | 2016 | β |
| Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1Ξ². | Ducheix S et al. | β | 2016 | β |
| Lack of mitochondria-generated acetyl-CoA by pyruvate dehydrogenase complex downregulates gene expression in the hepatic de novo lipogenic pathway. | Mahmood S et al. | β | 2016 | β |
| Liver PPARΞ± is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. | Montagner A et al. | β | 2016 | β |
| Metabolic adaptation of tissues to stress releases metabolites influencing innate immunity. | Naquet P et al. | β | 2016 | β |
| MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway. | Zhao G et al. | β | 2016 | β |
| Neil3-dependent base excision repair regulates lipid metabolism and prevents atherosclerosis in Apoe-deficient mice. | Skarpengland T et al. | β | 2016 | β |
| Nutritional and Hormonal Regulation of Citrate and Carnitine/Acylcarnitine Transporters: Two Mitochondrial Carriers Involved in Fatty Acid Metabolism. | Giudetti AM et al. | β | 2016 | β |
| Peroxisome Proliferator-Activated Receptor Activation is Associated with Altered Plasma One-Carbon Metabolites and B-Vitamin Status in Rats. | Lysne V et al. | β | 2016 | β |
| PPARs and Mitochondrial Metabolism: From NAFLD to HCC. | Mello T et al. | β | 2016 | β |
| Preventive effects of dietary walnuts on high-fat-induced hepatic fat accumulation, oxidative stress and apoptosis in mice. | Choi Y et al. | β | 2016 | β |
| Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. | Softic S et al. | β | 2016 | β |
| The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys. | Singh SB et al. | β | 2016 | β |
| Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity. | Flint TR et al. | β | 2016 | β |
| Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration. | Pisanti S et al. | β | 2015 | β |
| Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure. | Xu CX et al. | β | 2015 | β |
| De novo lipogenesis in metabolic homeostasis: More friend than foe? | Solinas G et al. | β | 2015 | β |
| Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity. | Duly AM et al. | β | 2015 | β |
| Ethanol Extract of Persimmon Tree Leaves Improves Blood Circulation and Lipid Metabolism in Rats Fed a High-Fat Diet. | Ryu R et al. | β | 2015 | β |
| Fasting-induced G0/G1 switch gene 2 and FGF21 expression in the liver are under regulation of adipose tissue derived fatty acids. | Jaeger D et al. | β | 2015 | β |
| Fatty acid signaling: the new function of intracellular lipases. | Papackova Z et al. | β | 2015 | β |
| Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | Al-Share QY et al. | β | 2015 | β |
| Hepatic Steatosis as a Marker of Metabolic Dysfunction. | Fabbrini E et al. | β | 2015 | β |
| Identifying causal regulatory SNPs in ChIP-seq enhancers. | Huang D et al. | β | 2015 | β |
| Lessons from hepatocyte-specific Cyp51 knockout mice: impaired cholesterol synthesis leads to oval cell-driven liver injury. | Lorbek G et al. | β | 2015 | β |
| Molecular mechanism of PPARΞ± action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. | Pawlak M et al. | β | 2015 | β |
| Molecular Pathways: Fatty Acid Synthase. | Jones SF et al. | β | 2015 | β |
| OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease. | Akie TE et al. | β | 2015 | β |
| Peroxisomal lipid synthesis regulates inflammation by sustaining neutrophil membrane phospholipid composition and viability. | Lodhi IJ et al. | β | 2015 | β |
| Postnatal Deletion of Fat Storage-inducing Transmembrane Protein 2 (FIT2/FITM2) Causes Lethal Enteropathy. | Goh VJ et al. | β | 2015 | β |
| PPARΞ± inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth. | Abu Aboud O et al. | β | 2015 | β |
| RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis. | Cui XB et al. | β | 2015 | β |
| Targeting fatty acid metabolism to improve glucose metabolism. | Stinkens R et al. | β | 2015 | β |
| 14-Deoxyandrographolide alleviates ethanol-induced hepatosteatosis through stimulation of AMP-activated protein kinase activity in rats. | Mandal S et al. | β | 2014 | β |
| A Moderate Zinc Deficiency Does Not Impair Gene Expression of PPARΞ±, PPARΞ³, and Mitochondrial Enoyl-CoA Delta Isomerase in the Liver of Growing Rats. | Justus J et al. | β | 2014 | β |
| CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). | Najjar SM et al. | β | 2014 | β |
| De novo lipogenesis in health and disease. | Ameer F et al. | β | 2014 | β |
| Energy metabolism in the liver. | Rui L | β | 2014 | β |
| Fatty acid synthase is required for mammary gland development and milk production during lactation. | Suburu J et al. | β | 2014 | β |
| Fetal and neonatal exposure to nicotine leads to augmented hepatic and circulating triglycerides in adult male offspring due to increased expression of fatty acid synthase. | Ma N et al. | β | 2014 | β |
| Gene doping in sport - perspectives and risks. | BrzeziaΕska E et al. | β | 2014 | β |
| Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation. | Chow JD et al. | β | 2014 | β |
| Genome sequencing and analysis of Mangalica, a fatty local pig of Hungary. | MolnΓ‘r J et al. | β | 2014 | β |
| Impairments of hepatic gluconeogenesis and ketogenesis in PPARΞ±-deficient neonatal mice. | Cotter DG et al. | β | 2014 | β |
| Intake levels of dietary polyunsaturated fatty acids modify the association between the genetic variation in PCSK5 and HDL cholesterol. | Jang HB et al. | β | 2014 | β |
| Integrated physiology and systems biology of PPARΞ±. | Kersten S | β | 2014 | β |
| Lipid metabolites as metabolic messengers in inter-organ communication. | Liu S et al. | β | 2014 | β |
| Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling. | Zhang D et al. | β | 2014 | β |
| miR-107 orchestrates ER stress induction and lipid accumulation by post-transcriptional regulation of fatty acid synthase in hepatocytes. | Bhatia H et al. | β | 2014 | β |
| Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. | Hassan K et al. | β | 2014 | β |
| Pathway-selective insulin resistance and metabolic disease: the importance of nutrient flux. | Otero YF et al. | β | 2014 | β |
| Plasma cis-vaccenic acid and risk of heart failure with antecedent coronary heart disease in male physicians. | DjoussΓ© L et al. | β | 2014 | β |
| Rosiglitazone, a PPAR-Ξ³ agonist, fails to attenuate CLA-induced milk fat depression and hepatic lipid accumulation in lactating mice. | Vyas D et al. | β | 2014 | β |
| Sox17 regulates liver lipid metabolism and adaptation to fasting. | Rommelaere S et al. | β | 2014 | β |
| Structural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variant. | Huang H et al. | β | 2014 | β |
| The development and functions of oenocytes. | Makki R et al. | β | 2014 | β |
| The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis. | Laggai S et al. | β | 2014 | β |
| Adipose-specific lipoprotein lipase deficiency more profoundly affects brown than white fat biology. | Garcia-Arcos I et al. | β | 2013 | β |
| A fatty gut feeling. | Piomelli D | β | 2013 | β |
| Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats. | Xin P et al. | β | 2013 | β |
| A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARΞ±. | Ducheix S et al. | β | 2013 | β |
| Caveolin-1 is necessary for hepatic oxidative lipid metabolism: evidence for crosstalk between caveolin-1 and bile acid signaling. | FernΓ‘ndez-Rojo MA et al. | β | 2013 | β |
| CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism. | Peterson JM et al. | β | 2013 | β |
| Dissociating fatty liver and diabetes. | Sun Z et al. | β | 2013 | β |
| Fatty acid metabolism: Implications for diet, genetic variation, and disease. | Suburu J et al. | β | 2013 | β |
| Fatty acid-regulated transcription factors in the liver. | Jump DB et al. | β | 2013 | β |
| Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. | Wu JH et al. | β | 2013 | β |
| Grape seed proanthocyanidin rescues rats from steatosis: a comparative and combination study with metformin. | Yogalakshmi B et al. | β | 2013 | β |
| Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation. | Ong KT et al. | β | 2013 | β |
| Impact of L-FABP and glucose on polyunsaturated fatty acid induction of PPARΞ±-regulated Ξ²-oxidative enzymes. | Petrescu AD et al. | β | 2013 | β |
| Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. | Sene A et al. | β | 2013 | β |
| Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice. | Ungerleider NA et al. | β | 2013 | β |
| Inhibitors of Fatty Acid Synthesis Induce PPAR Ξ± -Regulated Fatty Acid Ξ² -Oxidative Genes: Synergistic Roles of L-FABP and Glucose. | Huang H et al. | β | 2013 | β |
| Mitochondrial fatty acid oxidation in obesity. | Serra D et al. | β | 2013 | β |
| Modulation of fatty acid synthase degradation by concerted action of p38 MAP kinase, E3 ligase COP1, and SH2-tyrosine phosphatase Shp2. | Yu J et al. | β | 2013 | β |
| Modulation of fatty acid synthase enzyme activity and expression during hepatitis C virus replication. | Nasheri N et al. | β | 2013 | β |
| Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling. | Funai K et al. | β | 2013 | β |
| Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. | Koo SH | β | 2013 | β |
| Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARΞ±-dependent and -independent pathways. | Zhang H et al. | β | 2013 | β |
| Nutrient-dependent phosphorylation channels lipid synthesis to regulate PPARΞ±. | Jensen-Urstad AP et al. | β | 2013 | β |
| Peroxisome proliferator-activated receptor-Ξ³ in capillary endothelia promotes fatty acid uptake by heart during long-term fasting. | Goto K et al. | β | 2013 | β |
| Physiology: A metabolic minuet. | Moore DD | β | 2013 | β |
| PPAR-Ξ± as a key nutritional and environmental sensor for metabolic adaptation. | Contreras AV et al. | β | 2013 | β |
| Role of fat body lipogenesis in protection against the effects of caloric overload in Drosophila. | Musselman LP et al. | β | 2013 | β |
| Steatosis in the liver. | Wang DQ et al. | β | 2013 | β |
| The liver X receptor: a master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease. | Ducheix S et al. | β | 2013 | β |
| The potential of ΒΉΒΉC-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors. | Deford-Watts LM et al. | β | 2013 | β |
| A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. | Hugo SE et al. | β | 2012 | β |
| Autophagy links inflammasomes to atherosclerotic progression. | Razani B et al. | β | 2012 | β |
| Citrate carrier promoter is target of peroxisome proliferator-activated receptor alpha and gamma in hepatocytes and adipocytes. | Damiano F et al. | β | 2012 | β |
| Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells. | Bentsen H et al. | β | 2012 | β |
| Deletion of CaMKK2 from the liver lowers blood glucose and improves whole-body glucose tolerance in the mouse. | Anderson KA et al. | β | 2012 | β |
| Detailed transcriptomics analysis of the effect of dietary fatty acids on gene expression in the heart. | Georgiadi A et al. | β | 2012 | β |
| Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells. | Wurie HR et al. | β | 2012 | β |
| Drosophila melanogaster Acetyl-CoA-carboxylase sustains a fatty acid-dependent remote signal to waterproof the respiratory system. | Parvy JP et al. | β | 2012 | β |
| Effects of exercise training on molecular markers of lipogenesis and lipid partitioning in fructose-induced liver fat accumulation. | Yasari S et al. | β | 2012 | β |
| Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? | Jensen-Urstad AP et al. | β | 2012 | β |
| Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2. | Wei X et al. | β | 2012 | β |
| Functional Relationships between Lipid Metabolism and Liver Regeneration. | Rudnick DA et al. | β | 2012 | β |
| Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARΞ³ activation to decrease diet-induced obesity. | Lodhi IJ et al. | β | 2012 | β |
| Lipids and prostate cancer. | Suburu J et al. | β | 2012 | β |
| Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism. | Berger JH et al. | β | 2012 | β |
| Mechanisms of gene regulation by fatty acids. | Georgiadi A et al. | β | 2012 | β |
| Novel qualitative aspects of tissue fatty acids related to metabolic regulation: lessons from Elovl6 knockout. | Shimano H | β | 2012 | β |
| Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1Ξ±-Mediated Fatty Acid Oxidation. | Mulvihill EE et al. | β | 2012 | β |
| Supplementation of persimmon leaf ameliorates hyperglycemia, dyslipidemia and hepatic fat accumulation in type 2 diabetic mice. | Jung UJ et al. | β | 2012 | β |
| The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. | Farese RV et al. | β | 2012 | β |
| A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. | Peng D et al. | β | 2011 | β |
| Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. | Wu M et al. | β | 2011 | β |
| ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-Ξ± and PGC-1. | Haemmerle G et al. | β | 2011 | β |
| De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation. | Wei X et al. | β | 2011 | β |
| Fatty acid regulation of hepatic lipid metabolism. | Jump DB | β | 2011 | β |
| Fatty acid synthase modulates homeostatic responses to myocardial stress. | Razani B et al. | β | 2011 | β |
| Hepatocyte-specific IKK-Ξ² activation enhances VLDL-triglyceride production in APOE*3-Leiden mice. | van Diepen JA et al. | β | 2011 | β |
| Hepatosteatosis in peroxisome deficient liver despite increased Ξ²-oxidation capacity and impaired lipogenesis. | Peeters A et al. | β | 2011 | β |
| Hormonal and nutritional regulation of SCD1 gene expression. | Mauvoisin D et al. | β | 2011 | β |
| Human fatty liver disease: old questions and new insights. | Cohen JC et al. | β | 2011 | β |
| Human SREBP1c expression in liver is directly regulated by peroxisome proliferator-activated receptor alpha (PPARalpha). | FernΓ‘ndez-Alvarez A et al. | β | 2011 | β |
| Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. | Lodhi IJ et al. | β | 2011 | β |
| Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium L-glutamate in rats. | Lazarin Mde O et al. | β | 2011 | β |
| Liver X Receptor: an oxysterol sensor and a major player in the control of lipogenesis. | Ducheix S et al. | β | 2011 | β |
| Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo. | Wang S et al. | β | 2011 | β |
| New insights from rodent models of fatty liver disease. | Maher JJ | β | 2011 | β |
| Polyunsaturated fatty acid metabolism in prostate cancer. | Berquin IM et al. | β | 2011 | β |
| PPARs and lipid ligands in inflammation and metabolism. | Harmon GS et al. | β | 2011 | β |
| Proline- and acidic amino acid-rich basic leucine zipper proteins modulate peroxisome proliferator-activated receptor alpha (PPARalpha) activity. | Gachon F et al. | β | 2011 | β |
| Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. | Gambino R et al. | β | 2011 | β |
| Skeletal muscle lipid flux: running water carries no poison. | Funai K et al. | β | 2011 | β |
| Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. | Jump DB et al. | β | 2011 | β |
| Targeting Nuclear Hormone Receptors: PPARΞ± Agonists as Potential Disease-Modifying Drugs for Rheumatoid Arthritis. | Shirinsky IV et al. | β | 2011 | β |
| The metabolic serine hydrolases and their functions in mammalian physiology and disease. | Long JZ et al. | β | 2011 | β |
| The PPARΞ²/Ξ΄ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1Ξ±-Lipin 1-PPARΞ± pathway leading to increased fatty acid oxidation. | Barroso E et al. | β | 2011 | β |
| Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. | Zadravec D et al. | β | 2010 | β |
| Acyl-CoA binding protein gene ablation induces pre-implantation embryonic lethality in mice. | Landrock D et al. | β | 2010 | β |
| Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. | Mozaffarian D et al. | β | 2010 | β |
| Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice. | Wang Q et al. | β | 2010 | β |
| Discovery and characterization of a novel potent, selective and orally active inhibitor for mammalian ELOVL6. | Shimamura K et al. | β | 2010 | β |
| Endogenous ligand for an orphan receptor. | Wolf G | β | 2010 | β |
| Endogenous ligands for nuclear receptors: digging deeper. | Schupp M et al. | β | 2010 | β |
| Expression of fatty acid synthase in nonalcoholic fatty liver disease. | Dorn C et al. | β | 2010 | β |
| Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome. | Belfort R et al. | β | 2010 | β |
| Genetic control of de novo lipogenesis: role in diet-induced obesity. | Strable MS et al. | β | 2010 | β |
| Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways. | Bu SY et al. | β | 2010 | β |
| IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. | Ricardo-Gonzalez RR et al. | β | 2010 | β |
| Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms. | Chavez JA et al. | β | 2010 | β |
| Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis. | Lennerz JK et al. | β | 2010 | β |
| Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. | Schneider JG et al. | β | 2010 | β |
| Mice deficient in group VIB phospholipase A2 (iPLA2gamma) exhibit relative resistance to obesity and metabolic abnormalities induced by a Western diet. | Song H et al. | β | 2010 | β |
| Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. | Fabbrini E et al. | β | 2010 | β |
| PC-TP/StARD2: Of membranes and metabolism. | Kang HW et al. | β | 2010 | β |
| Peroxisome proliferator-activated receptor alpha (PPARalpha) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism. | Frigerio F et al. | β | 2010 | β |
| Peroxisome proliferator-activated receptor alpha target genes. | Rakhshandehroo M et al. | β | 2010 | β |
| Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A2 and diet-induced obesity. | LabontΓ© ED et al. | β | 2010 | β |
| PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1. | Okazaki M et al. | β | 2010 | β |
| PPARs: diverse regulators in energy metabolism and metabolic diseases. | Wang YX | β | 2010 | β |
| Recent insights into fatty liver, metabolic dyslipidaemia and their links to insulin resistance. | Savage DB et al. | β | 2010 | β |
| Role of PPARΞ± in Hepatic Carbohydrate Metabolism. | Peeters A et al. | β | 2010 | β |
| Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. | Burkhardt R et al. | β | 2010 | β |
| VLDL hydrolysis by LPL activates PPAR-alpha through generation of unbound fatty acids. | Ruby MA et al. | β | 2010 | β |
| Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice. | Wang Q et al. | β | 2009 | β |
| Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. | FernΓΈ J et al. | β | 2009 | β |
| Elovl6: a new player in fatty acid metabolism and insulin sensitivity. | Matsuzaka T et al. | β | 2009 | β |
| Fatty acid metabolism: target for metabolic syndrome. | Wakil SJ et al. | β | 2009 | β |
| Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer. | Menendez JA et al. | β | 2009 | β |
| Fatty acid synthesis and PPARalpha hand in hand. | Rotman N et al. | β | 2009 | β |
| Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice. | Oosterveer MH et al. | β | 2009 | β |
| Hepatic triacylglycerol accumulation and insulin resistance. | Nagle CA et al. | β | 2009 | β |
| Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity. | Sapiro JM et al. | β | 2009 | β |
| Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways. | Uebanso T et al. | β | 2009 | β |
| Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. | Rankin EB et al. | β | 2009 | β |
| Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. | Chakravarthy MV et al. | β | 2009 | β |
| Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation. | Chakravarthy MV et al. | β | 2009 | β |
| Metabolic disturbances in non-alcoholic fatty liver disease. | Byrne CD et al. | β | 2009 | β |
| Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver. | Sanderson LM et al. | β | 2009 | β |
| Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. | Flowers MT et al. | β | 2009 | β |
| Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. | Bu SY et al. | β | 2009 | β |
| The evolution of plasma cholesterol: direct utility or a "spandrel" of hepatic lipid metabolism? | Babin PJ et al. | β | 2009 | β |
| The molecular mechanism underlying the reduction in abdominal fat accumulation by licorice flavonoid oil in high fat diet-induced obese rats. | Honda K et al. | β | 2009 | β |
| Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models. | Newberry EP et al. | β | 2008 | β |
| Bezafibrate, a peroxisome proliferator-activated receptors agonist, decreases body temperature and enhances electroencephalogram delta-oscillation during sleep in mice. | Chikahisa S et al. | β | 2008 | β |
| Bis deficiency results in early lethality with metabolic deterioration and involution of spleen and thymus. | Youn DY et al. | β | 2008 | β |
| Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. | Rector RS et al. | β | 2008 | β |
| Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. | Postic C et al. | β | 2008 | β |
| Decreased fetal size is associated with beta-cell hyperfunction in early life and failure with age. | Chakravarthy MV et al. | β | 2008 | β |
| Diacylglycerol acyltransferases: Potential roles as pharmacological targets. | Zammit VA et al. | β | 2008 | β |
| Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. | Wang Y et al. | β | 2008 | β |
| Glucose homeostasis, insulin secretion, and islet phospholipids in mice that overexpress iPLA2beta in pancreatic beta-cells and in iPLA2beta-null mice. | Bao S et al. | β | 2008 | β |
| Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. | Reid BN et al. | β | 2008 | β |
| Hypothalamic malonyl-coenzyme A and the control of energy balance. | Wolfgang MJ et al. | β | 2008 | β |
| Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet. | Flowers MT et al. | β | 2008 | β |
| N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. | Jump DB | β | 2008 | β |
| [Nonalcoholic steatohepatitis: pathogenesis and treatment]. | Park SH | β | 2008 | β |
| Peroxisome proliferator-activated receptor alpha deficiency abolishes the response of lipogenic gene expression to re-feeding: restoration of the normal response by activation of liver X receptor alpha. | Hebbachi AM et al. | β | 2008 | β |
| PPARalpha activation and increased dietary lipid oppose thyroid hormone signaling and rescue impaired glucose-stimulated insulin secretion in hyperthyroidism. | Holness MJ et al. | β | 2008 | β |
| Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance. | Sugden MC et al. | β | 2008 | β |
| Serial changes in expression of functionally clustered genes in progression of liver fibrosis in hepatitis C patients. | Takahara Y et al. | β | 2008 | β |
| Transcriptional regulation of hepatic fatty acid metabolism. | Guillou H et al. | β | 2008 | β |
| An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. | Bernal-Mizrachi C et al. | β | 2007 | β |
| Atherosclerosis, cholesterol, nutrition, and statins--a critical review. | Gebbers JO | β | 2007 | β |
| Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. | Chakravarthy MV et al. | β | 2007 | β |
| Cannabinoids: a new group of agonists of PPARs. | Sun Y et al. | β | 2007 | β |
| Conditional animal models for the study of lipid metabolism and lipid disorders. | Bock HH et al. | β | 2007 | β |
| Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. | Matsuzaka T et al. | β | 2007 | β |
| Dietary fat-gene interactions in cancer. | Chen YQ et al. | β | 2007 | β |
| Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver. | Morral N et al. | β | 2007 | β |
| Fatty acid synthase inhibitors: new directions for oncology. | Kridel SJ et al. | β | 2007 | β |
| Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. | Badman MK et al. | β | 2007 | β |
| Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. | Miyazaki M et al. | β | 2007 | β |
| In appreciation of Sir Philip Randle: the glucose-fatty acid cycle. | Sugden MC | β | 2007 | β |
| Lessons from "lower" organisms: what worms, flies, and zebrafish can teach us about human energy metabolism. | Schlegel A et al. | β | 2007 | β |
| Sex-specific effect of the Val1483Ile polymorphism in the fatty acid synthase gene (FAS) on body mass index and lipid profile in Caucasian children. | KΓΆrner A et al. | β | 2007 | β |
| Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. | Sampath H et al. | β | 2007 | β |
| The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid. | Guo F et al. | β | 2007 | β |
| A targeted apoB38.9 mutation in mice is associated with reduced hepatic cholesterol synthesis and enhanced lipid peroxidation. | Lin X et al. | β | 2006 | β |
| Control of energy homeostasis: role of enzymes and intermediates of fatty acid metabolism in the central nervous system. | Wolfgang MJ et al. | β | 2006 | β |
| Ins and outs modulating hepatic triglyceride and development of nonalcoholic fatty liver disease. | Goldberg IJ et al. | β | 2006 | β |
| Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. | Mao J et al. | β | 2006 | β |
| Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. | Sugden MC et al. | β | 2006 | β |
| Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. | Begriche K et al. | β | 2006 | β |
| New insights in the pathogenesis of non-alcoholic fatty liver disease. | Gaemers IC et al. | β | 2006 | β |
| Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes. | Li LO et al. | β | 2006 | β |
| Signalling mechanisms linking hepatic glucose and lipid metabolism. | Weickert MO et al. | β | 2006 | β |
| Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. | Lefebvre P et al. | β | 2006 | β |
| Stable isotope methods for the in vivo measurement of lipogenesis and triglyceride metabolism. | Murphy EJ | β | 2006 | β |
| Comparative aspects of lipid metabolism: impact on contemporary research and use of animal models. | Bergen WG et al. | β | 2005 | β |
| Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit. | Cassuto H et al. | β | 2005 | β |
| Old fat, make way for new fat. | Gibbons G | β | 2005 | β |
| PPARalpha: savior or savage? | Schneider JG et al. | β | 2005 | β |